Correlation Between Vertex Pharmaceutic and Immunoprecise Antibodies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceutic and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceutic and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceutic and Immunoprecise Antibodies, you can compare the effects of market volatilities on Vertex Pharmaceutic and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceutic with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceutic and Immunoprecise Antibodies.

Diversification Opportunities for Vertex Pharmaceutic and Immunoprecise Antibodies

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Vertex and Immunoprecise is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceutic and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and Vertex Pharmaceutic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceutic are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of Vertex Pharmaceutic i.e., Vertex Pharmaceutic and Immunoprecise Antibodies go up and down completely randomly.

Pair Corralation between Vertex Pharmaceutic and Immunoprecise Antibodies

Given the investment horizon of 90 days Vertex Pharmaceutic is expected to generate 0.21 times more return on investment than Immunoprecise Antibodies. However, Vertex Pharmaceutic is 4.82 times less risky than Immunoprecise Antibodies. It trades about 0.04 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about -0.01 per unit of risk. If you would invest  22,858  in Vertex Pharmaceutic on March 31, 2022 and sell it today you would earn a total of  5,258  from holding Vertex Pharmaceutic or generate 23.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vertex Pharmaceutic  vs.  Immunoprecise Antibodies

 Performance (%) 
      Timeline 
Vertex Pharmaceutic 
Vertex Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceutic are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Vertex Pharmaceutic may actually be approaching a critical reversion point that can send shares even higher in July 2022.

Structure and Payout Changes

Last Split Factor
2:1
Last Split Date
2000-08-24

Vertex Price Channel

Immunoprecise Antibodies 
Immunoprecise Performance
0 of 100
Over the last 90 days Immunoprecise Antibodies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in July 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Immunoprecise Price Channel

Vertex Pharmaceutic and Immunoprecise Antibodies Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Vertex Pharmaceutic and Immunoprecise Antibodies

The main advantage of trading using opposite Vertex Pharmaceutic and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceutic position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.
The idea behind Vertex Pharmaceutic and Immunoprecise Antibodies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Immunoprecise Antibodies

Pair trading matchups for Immunoprecise Antibodies

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go